Lithium 4,6-Dichloropyridazine-3-carboxylate Hydrate
医药中间体 · — · —
医药中间体Confidentiality：公开
- INN / Generic Name
- Lithium 4,6-Dichloropyridazine-3-carboxylate Hydrate
- CAS No.
- 2245111-15-1
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Deucravacitinib
- Current Status
- 官方中间体目录（API: Deucravacitinib）
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO 供货（非注册物质）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —